Skip to main content
    T

    The Cigna Group (CI)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $300.14
    +3.14 (+1.06%)

    Market Cap: $78.26B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    The Cigna Group (CI) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    The Cigna Group (CI) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, The Cigna Group reported EPS of $7.98, above the $7.46 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +6.19%
    Streak
    7 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$7.32
    Range$6.91 - $7.83
    28 analysts
    Revenue Consensus
    $77.59B
    Range$72.93B - $80.52B
    21 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$8.35
    Range$7.89 - $9.00
    15 analysts
    EPS Revisions
    4
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$8.27+1.0%
    60d ago$8.28+0.9%
    30d ago$8.33+0.3%
    7d ago$8.36-0.1%
    Current$8.35
    Revenue Consensus
    $71.46B
    Range$69.66B - $76.43B
    8 analysts

    Next Report

    CI has an expected report date of Feb 3, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 9.4% below the $8.08 reported for the quarter ended Dec 31, 2025.

    CI Earnings Call

    The latest CI earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CI beat 37 and missed 3. Revenue for the quarter ended Sep 30, 2026 was $73.72B, up 5.6% from $69.81B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$7.98$7.46$7.42 - $7.71+6.97%Beat+1.9%231 up, 1 downNov 5, 2026$73.72B
    Jun 30, 2026$7.78$7.58$7.53 - $7.73+2.64%Beat+8.1%222 up, 0 downJul 30, 2026$71.61B
    Mar 31, 2026$7.79$7.61$7.09 - $7.92+2.37%Beat+15.6%220 up, 2 downApr 30, 2026$68.76B
    Dec 31, 2025$8.08$7.88$7.82 - $8.00+2.54%Beat+21.7%221 up, 1 downFeb 5, 2026$72.30B
    Sep 30, 2025$7.83$7.64$7.41 - $8.28+2.49%Beat+4.3%231 up, 4 downOct 30, 2025$69.81B
    Jun 30, 2025$7.20$7.15$7.08 - $7.39+0.70%Beat+7.1%221 up, 1 downJul 31, 2025$67.23B
    Mar 31, 2025$6.74$6.35$5.81 - $6.78+6.14%Beat+4.2%211 up, 3 downMay 2, 2025$65.54B
    Dec 31, 2024$6.64$7.82$7.72 - $8.10-15.09%Miss-2.2%222 up, 0 downJan 30, 2025$64.01B
    Sep 30, 2024$7.51$7.25$7.10 - $7.67+3.59%Beat+10.9%201 up, 0 downOct 31, 2024$62.69B
    Jun 30, 2024$6.72$6.42$6.29 - $6.71+4.67%Beat+9.6%211 up, 0 downAug 1, 2024$60.48B
    Mar 31, 2024$6.47$6.22$6.04 - $6.54+4.02%Beat+19.6%212 up, 0 downMay 1, 2024$57.24B
    Dec 31, 2023$6.79$6.54$6.45 - $6.69+3.82%Beat+36.9%201 up, 0 downFeb 2, 2024$49.60B
    Sep 30, 2023$6.77$6.68$6.58 - $6.84+1.35%Beat+12.1%190 up, 0 downNov 2, 2023$49.01B
    Jun 30, 2023$6.13$6.04$5.54 - $6.24+1.49%Beat-1.4%210 up, 1 downAug 3, 2023$48.61B
    Mar 31, 2023$5.41$5.24$4.96 - $6.13+3.24%Beat-10.0%212 up, 0 downMay 5, 2023$46.46B
    Dec 31, 2022$4.96$4.87$4.74 - $5.01+1.85%Beat+4.0%210 up, 0 downFeb 3, 2023$45.36B
    Sep 30, 2022$6.04$5.71$5.56 - $6.07+5.78%Beat+5.4%183 up, 0 downNov 3, 2022$46.93B
    Jun 30, 2022$6.22$5.49$5.04 - $5.85+13.30%Beat+18.7%210 up, 0 downAug 4, 2022$45.39B
    Mar 31, 2022$6.01$5.18$4.63 - $5.45+16.02%Beat+27.1%192 up, 2 downMay 6, 2022$44.01B
    Dec 31, 2021$4.77$4.71$4.50 - $5.14+1.27%Beat+35.9%210 up, 0 downFeb 3, 2022$45.88B
    Sep 30, 2021$5.73$5.21$4.84 - $5.68+9.98%Beat+29.9%23N/ANov 4, 2021$44.29B
    Jun 30, 2021$5.24$4.97$4.45 - $5.67+5.43%Beat-9.8%21N/AAug 5, 2021$43.12B
    Mar 31, 2021$4.73$4.40$3.99 - $5.56+7.50%Beat+0.9%20N/AMay 7, 2021$40.84B
    Dec 31, 2020$3.51$3.69$3.49 - $3.97-4.88%Miss-18.6%22N/AFeb 4, 2021$46.08B
    Sep 30, 2020$4.41$4.23$4.01 - $4.58+4.26%Beat-2.9%23N/ANov 5, 2020$40.99B
    Jun 30, 2020$5.81$5.16$4.73 - $6.11+12.60%Beat+35.1%24N/AJul 30, 2020$39.29B
    Mar 31, 2020$4.69$4.36$4.11 - $5.14+7.57%Beat+20.3%22N/AApr 30, 2020$38.20B
    Dec 31, 2019$4.31$4.20$4.15 - $4.28+2.62%Beat+75.2%25N/AFeb 6, 2020$38.35B
    Sep 30, 2019$4.54$4.36$4.05 - $4.61+4.13%Beat+18.2%25N/AOct 31, 2019$38.61B
    Jun 30, 2019$4.30$3.74$3.58 - $4.34+14.97%Beat+10.5%23N/AAug 1, 2019$38.84B
    Mar 31, 2019$3.90$3.73$3.47 - $4.63+4.56%Beat-5.1%24N/AMay 2, 2019$37.95B
    Dec 31, 2018$2.46$2.49$1.66 - $2.74-1.20%Miss+26.8%17N/AFeb 1, 2019$14.22B
    Sep 30, 2018$3.84$3.44$3.13 - $3.60+11.63%Beat+35.7%21N/ANov 1, 2018$11.46B
    Jun 30, 2018$3.89$3.33$3.03 - $3.70+16.82%Beat+33.7%19N/AAug 2, 2018$11.48B
    Mar 31, 2018$4.11$3.39$3.20 - $3.68+21.24%Beat+48.4%19N/AMay 3, 2018$11.41B
    Dec 31, 2017$1.94$1.87$1.79 - $2.14+3.74%Beat+3.7%19N/AFeb 1, 2018$10.42B
    Sep 30, 2017$2.83$2.36$2.25 - $2.47+19.92%Beat+45.9%14N/ANov 2, 2017$10.49B
    Jun 30, 2017$2.91$2.48$2.36 - $2.56+17.34%Beat+47.0%18N/AAug 4, 2017$10.43B
    Mar 31, 2017$2.77$2.46N/A+12.60%Beat+19.4%N/AN/AMay 5, 2017$10.47B
    Dec 31, 2016$1.87$1.74N/A+7.47%Beat0.0%N/AN/AFeb 2, 2017$9.94B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $29.85, up 9.2% from the year before. It was $8.11 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$29.85+9.2%
    Dec 31, 2024$27.34+8.9%
    Dec 31, 2023$25.10+8.0%
    Dec 31, 2022$23.23+13.5%
    Dec 31, 2021$20.47+11.1%
    Dec 31, 2020$18.42+8.0%
    Dec 31, 2019$17.05+19.2%
    Dec 31, 2018$14.30+36.8%
    Dec 31, 2017$10.45+28.9%
    Dec 31, 2016$8.11N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,600 words across 14 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,61914
    2026Q2Jun 30, 20268,48414
    2026Q1Mar 31, 202610,18715
    2025Q4Dec 31, 20259,32415
    2025Q3Sep 30, 20256,0768
    2025Q2Jun 30, 20259,44214
    2025Q1Mar 31, 20259,78514
    2024Q4Dec 31, 20249,96919

    2026Q3 Earnings Call

    Opening remarks

    Ralph Giacobbe Senior Vice President of Investor Relations Great, thanks. Good morning. Thank you for joining today's call. I am Ralph Giacobbe, Senior Vice President of Investor Relations. With me on the line this morning are Brian C. Evanko, Cigna Group's President and Chief Executive Officer, and Ann Dennison, Chief Financial Officer. In our remarks today, Brian and Ann will cover a number of topics, including our third-quarter 2026 financial results and our financial outlook for 2026. Following their prepared remarks, Brian and Ann will be available for Q&A. As noted in our earnings release, when describing our financial results, we use certain financial measures, including adjusted income from operations and adjusted revenues, that are not determined in accordance with accounting principles generally accepted in the United States, otherwise known as GAAP. A reconciliation of these measures to the most directly comparable GAAP measures, shareholders' net income and total revenues, respectively, is contained in today's earnings release, which is posted in the Investor Relations section of cignagroup.com. We use the terms adjusted income from operations and adjusted earnings per share as our principal measures of financial performance. In our remarks today, we will be making some forward-looking statements, including statements regarding our outlook for 2026 and future performance. These statements are subject to risks and uncertainties that could cause actual results to differ materially from our current expectations. A description of these risks and uncertainties is contained in the cautionary note to today's earnings release and in our most recent reports filed with the SEC. Regarding our results in the third quarter, we recorded after-tax special item charges of $146 million, or $0.55 per share. Details of the special items are included in our quarterly financial supplement. Additionally, please note that when we make prospective comments regarding financial performance, including our full-year 2026 outlook, we will do so on a basis that includes the potential impact of future share repurchases and anticipated 2026 dividends. With that, I will turn the call over to Brian.

    Brian C. Evanko President and Chief Executive Officer Thanks, Ralph. Good morning, everyone, and thank you for joining our call. I am pleased to share that the Cigna Group delivered strong performance in the third quarter as we continue executing on our strategy. Today, I will cover our results for the quarter and key drivers, our profitable growth strategy and how we are advancing toward our long-term earnings growth algorithm of 10% to 14%, which we laid out at our recent Investor Day, as well as how our strategic growth framework positions us to build momentum in 2027. Then Ann will share additional details about our financial results and outlook for the rest of the year, and we will take your questions.

    Frequently Asked Questions About CI

    When is The Cigna Group's next earnings date?

    The Cigna Group's next earnings report is expected for Feb 3, 2027.

    Did CI beat earnings estimates last quarter?

    Yes. The Cigna Group reported EPS of $7.98 for the quarter ended Sep 30, 2026, above the $7.46 estimate, a 6.97% surprise.

    What EPS do analysts expect from CI next quarter?

    The consensus EPS estimate for The Cigna Group for the quarter ending Dec 31, 2026 is $7.32 from 28 analysts, with estimates from $6.91 to $7.83.

    How often does CI beat earnings estimates?

    The Cigna Group beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +1.09%.